These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35899209)

  • 1. Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer.
    Hofmann L; Medyany V; Ezić J; Lotfi R; Niesler B; Röth R; Engelhardt D; Laban S; Schuler PJ; Hoffmann TK; Brunner C; Jackson EK; Theodoraki MN
    Front Med (Lausanne); 2022; 9():904295. PubMed ID: 35899209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plasma- and saliva-derived exosomal miRNA profiles reveals diagnostic potential in head and neck cancer.
    Hofmann L; Abou Kors T; Ezić J; Niesler B; Röth R; Ludwig S; Laban S; Schuler PJ; Hoffmann TK; Brunner C; Medyany V; Theodoraki MN
    Front Cell Dev Biol; 2022; 10():971596. PubMed ID: 36072342
    [No Abstract]   [Full Text] [Related]  

  • 3. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
    Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
    Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of plasma-derived exosomes into CD3
    Theodoraki MN; Hoffmann TK; Whiteside TL
    Clin Exp Immunol; 2018 Jun; 192(3):271-283. PubMed ID: 29431869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells
    Langevin S; Kuhnell D; Parry T; Biesiada J; Huang S; Wise-Draper T; Casper K; Zhang X; Medvedovic M; Kasper S
    Oncotarget; 2017 Oct; 8(47):82459-82474. PubMed ID: 29137278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.
    Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma‑derived CD16 exosomes and peripheral blood monocytes as correlating biomarkers in head and neck cancer.
    Theodoraki MN; Hofmann L; Huber D; Brunner C; Hoffmann TK; Idel C; Fleckner J; Bruchhage KL; Pries R
    Oncol Lett; 2023 May; 25(5):200. PubMed ID: 37113401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of PD-L1
    Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
    Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.
    Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL
    Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes.
    Affolter A; Liebel K; Tengler L; Seiz E; Tiedtke M; Azhakesan A; Schütz J; Theodoraki MN; Kern J; Ruder AM; Fleckenstein J; Weis CA; Bieback K; Kramer B; Lammert A; Scherl C; Rotter N; Ludwig S
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
    Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
    Ludwig N; Gillespie DG; Reichert TE; Jackson EK; Whiteside TL
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
    Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
    Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients.
    Theodoraki MN; Laban S; Jackson EK; Lotfi R; Schuler PJ; Brunner C; Hoffmann TK; Whiteside TL; Hofmann L
    Br J Cancer; 2021 Dec; 125(12):1677-1686. PubMed ID: 34642463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Exosomes Inhibit B Cell Proliferation and Activity.
    Schroeder JC; Puntigam L; Hofmann L; Jeske SS; Beccard IJ; Doescher J; Laban S; Hoffmann TK; Brunner C; Theodoraki MN; Schuler PJ
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment dependent impact of plasma-derived exosomes from head and neck cancer patients on the epithelial-to-mesenchymal transition.
    Hofmann L; Waizenegger M; Röth R; Schmitteckert S; Engelhardt D; Schuler PJ; Laban S; Hoffmann TK; Brunner C; Theodoraki MN
    Front Oncol; 2022; 12():1043199. PubMed ID: 36686733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
    Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
    Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
    Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
    Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
    Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in salivary exosomal miRNAs in head and neck squamous carcinoma].
    He J; Yang L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 38(3):261-266. PubMed ID: 38433699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.